• Japanese
  • Korean
  • Chinese
Cover Image

Worldwide Market for Surgical Sealants, Glues, Wound Closure and Anti-Adhesion, 2012-2017

This report will detail the complete range of sealants & glues technologies used in traumatic, surgical and other wound closure, including tapes, sutures/staples/mechanical closure, hemostats, fibrin sealants/glues and medical adhesives and anti-adhesion products.

The report will detail current clinical and technology developments, with data on products in development (detailing market status) and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity. The report will provide full year actual data from 2011. The report will provide a worldwide forecast to 2017 of the markets for these technologies, with particular emphasis on the market impact of new technologies through the forecast period. The report will provide specific forecasts and shares of the worldwide market by segment for Americas (detail for U.S., Rest of North America and Latin America), Europe (detail for United Kingdom, German, France, Italy, Spain, Rest of Europe), Asia/Pacific (detail for Japan, Korea, Rest of Asia/Pacific) and Rest of World.

The report will also provide background data on the surgical, disease and traumatic wound patient populations targeted by current technologies and those under development, and the current clinical practices in the management of these patients, including the dynamics among the various clinical specialties or subspecialties vying for patient population and facilitating or limiting the growth of technologies. The report will establish the current worldwide market size for major technology segments as a baseline for and projecting growth in the market through 2017. The report will also assess and project the composition of the market as technologies gain or lose relative market performance over this period. The report will profile a minimum of 100 companies in this industry, providing data on their current products, current market position and products under development.

Table of Contents

EXECUTIVE SUMMARY

SECTION 1: CLINICAL NEED, CASELOAD AND PROCEDURE VOLUME

  • 1.1. Anatomy and Physiology of Tissue Repair
  • 1.2. The Skin
  • 1.3. Internal Tissues and Organ
  • 1.4. Wound Classification and Types
    • 1.4.1. Classification by Morphology and Severity
    • 1.4.2. Classification by Cause
    • 1.4.3. Surgical Wounds
  • 1.5. Caseload
    • 1.5.1. Cardiovascular
      • 1.5.5.1. Coronary Heart Disease
      • 1.5.1.2. Dysfunctional Heart Valves
      • 1.5.1.3. Peripheral Vascular Disorders
      • 1.5.1.4. Abnormal Aortic Aneurysms
      • 1.5.1.5. Drivers of Caseloads for Cardiac Surgery
    • 1.5.2. Neurological
      • 1.5.2.1. Stroke
      • 1.5.2.2. Parkinson's Disease
      • 1.5.2.3. Epilepsy
      • 1.5.2.4. Traumatic Injury
      • 1.5.2.5. Peripheral Nerve Treatment
      • 1.5.2.6. Drivers of Neurological Surgery
    • 1.5.3. Orthopedic
      • 1.5.3.1. Hip Replacement
      • 1.5.3.2. Knee Replacements
      • 1.5.3.3. Cartilage Repair
      • 1.5.3.4. Ligament Damage
      • 1.5.3.5. Bone Grafting
      • 1.5.3.6. Vertebral Disc Repair
      • 1.5.3.7. Drivers of Orthopedic Surgery
    • 1.5.4. Urological
      • 1.5.4.1. Incontinence
      • 1.5.4.2. Drivers of Urological Surgery
    • 1.5.5. Dermatological
      • 1.5.5.1. Burns
      • 1.5.5.2. Pressure Ulcers
      • 1.5.5.3. Diabetic Ulcers
      • 1.5.5.4. Venous Ulcers
      • 1.5.5.5. Plastic Surgery
      • 1.5.5.6. Drivers of Dermatological Surgery
  • 1.6. The Role of Modern Sealant, Securement and Hemostatic Products in Surgery
    • 1.6.1. Fibrin Sealants
    • 1.6.2. High-Strength Glues

SECTION 2: SCIENCE, TECHNOLOGY, DEVELOPMENT, CLINICAL AND REGULATORY CHALLENGES

  • 2.1. Tissue Healing
    • 2.1.1. Hemostasis
    • 2.1.2. Proliferation and Maturation
    • 2.1.3. Factors That Affect Healing
  • 2.2. Product Development
  • 2.3. Development Timelines
    • 2.3.1. Collagen and Thrombin Combination
    • 2.3.2. Polyethylene Glycol Polymer (PEG)
    • 2.3.3. Albumin Cross-Linked with Glutaraldehyde
    • 2.3.4. Delivery Systems
  • 2.4. Cost-Effectiveness
  • 2.5. Regulatory Challenges
    • 2.5.1. Approval Processes
    • 2.5.2. History of Product Development
    • 2.5.3. Regulatory Aspects

SECTION 3: PRODUCTS, TECHNOLOGIES, AND FORECAST OPPORTUNITY

  • 3.1. Overview
    • 3.1.1. Development Timeline
  • 3.2. Sutures, Staples and other Mechanical Closure Devices
    • 3.2.1. Sutures, Staples and Mechanical Closure Competitors and Products
    • 3.2.2. Sutures, Staples and Mechanical Closure Products in Development
    • 3.2.3. Sutures, Staples and Mechanical Closure Market Analysis and Forecast
  • 3.3. Tapes
    • 3.3.1. Medical Tape Competitors and Products
    • 3.3.2. Medical Tape Market Analysis and Forecast
  • 3.4. Hemostats
    • 3.4.1. Hemostat Competitors and Products
    • 3.4.2. Hemostat Products in Development
    • 3.4.3. Hemostat Market Analysis and Forecasts
  • 3.5. Fibrin and Other Sealant Products
    • 3.5.1. Fibrin and Other Sealant Competitors and Products
    • 3.5.2. Fibrin and Other Sealant Products in Development
    • 3.5.3. Fibrin and Other Sealant Market Analysis and Forecasts
  • 3.6. High-Strength Medical Adhesives
    • 3.6.1. High-Strength Medical Adhesive Competitors and Products
    • 3.6.2. High-Strength Medical Adhesive Products in Development
    • 3.6.3. High-Strength Medical Adhesive Market Analysis and Forecasts
  • 3.7. Post-Surgical Adhesion Prevention
    • 3.7.1. Post-Surgical Adhesion Prevention Competitors and Products
    • 3.7.2. Post-Surgical Adhesion Prevention Products in Development
    • 3.7.3. Post-Surgical Adhesion Prevention Market Analysis and Forecasts
  • 3.8. Wound Closure and Securement Markets: Global and Regional Analysis
    • 3.8.1. Americas
    • 3.8.2. European Union
    • 3.8.3. Asia-Pacific
    • 3.8.4. Rest of World
  • 3.9. Worldwide Markets By Country and Segment
    • 3.9.1. Americas
      • 3.9.1.1. United States
        • 3.9.1.1.1. Sutures & Staples
        • 3.9.1.1.2. Mechanical Closure
        • 3.9.1.1.3. Tapes
        • 3.9.1.1.4. Hemostats
        • 3.9.1.1.5. Fibrin & Other Sealants
        • 3.9.1.1.6. High-Strength Medical Adhesives
        • 3.9.1.1.7. Post-Surgical Adhesion Prevention
      • 3.9.1.2. Rest of North America
        • 3.9.1.2.1. Sutures & Staples
        • 3.9.1.2.2. Mechanical Closure
        • 3.9.1.2.3. Tapes
        • 3.9.1.2.4. Hemostats
        • 3.9.1.2.5. Fibrin & Other Sealants
        • 3.9.1.2.6. High-Strength Medical Adhesives
        • 3.9.1.2.7. Post-Surgical Adhesion Prevention
      • 3.9.1.3. Latin America
        • 3.9.1.3.1. Sutures & Staples
        • 3.9.1.3.2. Mechanical Closure
        • 3.9.1.3.3. Tapes
        • 3.9.1.3.4. Hemostats
        • 3.9.1.3.5. Fibrin & Other Sealants
        • 3.9.1.3.6. High-Strength Medical Adhesives
        • 3.9.1.3.7. Post-Surgical Adhesion Prevention
    • 3.9.2. European Union
      • 3.9.2.1. United Kingdom
        • 3.9.2.1.1. Sutures & Staples
        • 3.9.2.1.2. Mechanical Closure
        • 3.9.2.1.3. Tapes
        • 3.9.2.1.4. Hemostats
        • 3.9.2.1.5. Fibrin & Other Sealants
        • 3.9.2.1.6. High-Strength Medical Adhesives
        • 3.9.2.1.7. Post-Surgical Adhesion Prevention
      • 3.9.2.2. Germany
        • 3.9.2.2.1. Sutures & Staples
        • 3.9.2.2.2. Mechanical Closure
        • 3.9.2.2.3. Tapes
        • 3.9.2.2.4. Hemostats
        • 3.9.2.2.5. Fibrin & Other Sealants
        • 3.9.2.2.6. High-Strength Medical Adhesives
        • 3.9.2.2.7. Post-Surgical Adhesion Prevention
      • 3.9.2.3. France
        • 3.9.2.3.1. Sutures & Staples
        • 3.9.2.3.2. Mechanical Closure
        • 3.9.2.3.3. Tapes
        • 3.9.2.3.4. Hemostats
        • 3.9.2.3.5. Fibrin & Other Sealants
        • 3.9.2.3.6. High-Strength Medical Adhesives
        • 3.9.2.3.7. Post-Surgical Adhesion Prevention
      • 3.9.2.4. Spain
        • 3.9.2.4.1. Sutures & Staples
        • 3.9.2.4.2. Mechanical Closure
        • 3.9.2.4.3. Tapes
        • 3.9.2.4.4. Hemostats
        • 3.9.2.4.5. Fibrin & Other Sealants
        • 3.9.2.4.6. High-Strength Medical Adhesives
        • 3.9.2.4.7. Post-Surgical Adhesion Prevention
      • 3.9.2.5. Italy
        • 3.9.2.5.1. Sutures & Staples
        • 3.9.2.5.2. Mechanical Closure
        • 3.9.2.5.3. Tapes
        • 3.9.2.5.4. Hemostats
        • 3.9.2.5.5. Fibrin & Other Sealants
        • 3.9.2.5.6. High-Strength Medical Adhesives
        • 3.9.2.5.7. Post-Surgical Adhesion Prevention
      • 3.9.2.6. Rest of Europe
        • 3.9.2.6.1. Sutures & Staples
        • 3.9.2.6.2. Mechanical Closure
        • 3.9.2.6.3. Tapes
        • 3.9.2.6.4. Hemostats
        • 3.9.2.6.5. Fibrin & Other Sealants
        • 3.9.2.6.6. High-Strength Medical Adhesives
        • 3.9.2.6.7. Post-Surgical Adhesion Prevention
    • 3.9.3. Asia-Pacific
      • 3.9.3.1. Japan
        • 3.9.3.1.1. Sutures & Staples
        • 3.9.3.1.2. Mechanical Closure
        • 3.9.3.1.3. Tapes
        • 3.9.3.1.4. Hemostats
        • 3.9.3.1.5. Fibrin & Other Sealants
        • 3.9.3.1.6. High-Strength Medical Adhesives
        • 3.9.3.1.7. Post-Surgical Adhesion Prevention
      • 3.9.3.2. Korea
        • 3.9.3.2.1. Sutures & Staples
        • 3.9.3.2.2. Mechanical Closure
        • 3.9.3.2.3. Tapes
        • 3.9.3.2.4. Hemostats
        • 3.9.3.2.5. Fibrin & Other Sealants
        • 3.9.3.2.6. High-Strength Medical Adhesives
        • 3.9.3.2.7. Post-Surgical Adhesion Prevention
      • 3.9.3.3. Rest of Asia-Pacific
        • 3.9.3.3.1. Sutures & Staples
        • 3.9.3.3.2. Mechanical Closure
        • 3.9.3.3.3. Tapes
        • 3.9.3.3.4. Hemostats
        • 3.9.3.3.5. Fibrin & Other Sealants
        • 3.9.3.3.6. High-Strength Medical Adhesives
        • 3.9.3.3.7. Post-Surgical Adhesion Prevention
    • 3.9.4. Rest of World
      • 3.9.4.1. Sutures & Staples
      • 3.9.4.2. Mechanical Closure
      • 3.9.4.3. Tapes
      • 3.9.4.4. Hemostats
      • 3.9.4.5. Fibrin & Other Sealants
      • 3.9.4.6. High-Strength Medical Adhesives
      • 3.9.4.7. Post-Surgical Adhesion Prevention

SECTION 4: COMPANY PROFILES

  • 4.1. 3M
  • 4.2. Abbott Laboratories
  • 4.3. AccessClosure, Inc.
  • 4.4. Adhesives Research, Inc.
  • 4.5. Adhezion Biomedical, LLC
  • 4.6. Advanced Medical Solutions Group plc/Medlogic Global
  • 4.7. Advanced Vascular Dynamics
  • 4.8. Aeris Therapeutics
  • 4.9. Alafair Biosciences, Inc.
  • 4.10. Angiotech Pharmaceuticals, Inc.
  • 4.11. Anika Therapeutics, Inc.
  • 4.12. ArthroCare Corporation
  • 4.13. ARW Industries
  • 4.14. Aso LLC
  • 4.15. Aspen Surgical Products
  • 4.16. Avery Dennison
  • 4.17. B. Braun (Braun Melsungen AG)
  • 4.18. Baxter International Inc.
  • 4.19. Beeken BioMedical, LLC
  • 4.20. Bernsco Surgical Supply (George Tiemann & Co.)
  • 4.21. Biocoral Inc.
  • 4.22. Bioster a.s.
  • 4.23. Biotronik SE & Co., KG
  • 4.24. BSN Medical
  • 4.25. C.R. Bard (Bard Medical, Davol)
  • 4.26. Canica Design, Inc.
  • 4.27. Cardiovascular Sciences, Inc.
  • 4.28. Cardiva Medical, Inc.
  • 4.29. Celox Medical, Inc.
  • 4.30. Ceremed, Inc.
  • 4.31. Chemence Medical
  • 4.32. Chesson Laboratory Associates, Inc.
  • 4.33. Cohera Medical, Inc.
  • 4.34. Coloplast A/S
  • 4.35. ConMed, Inc.
  • 4.36. Cordis Corporation (JNJ)
  • 4.37. Covidien Ltd.
  • 4.38. CryoLife Inc.
  • 4.39. CSIRO PhotoMedical Technologies
  • 4.40. CSL Behring
  • 4.41. CSMG Technologies, Inc. (Live Tissue Connect, Inc.)
  • 4.42. CuraMedical BV
  • 4.43. Derma Sciences, Inc.
  • 4.44. DuPont Applied BioSciences
  • 4.45. Dynamic Techno Medicals Pvt. Ltd.
  • 4.46. Entegrion, Inc.
  • 4.47. Equimedical B.V.
  • 4.48. Ferndale Laboratories
  • 4.49. FibroGen, Inc.
  • 4.50. FzioMed Inc.
  • 4.51. Gelita Medical BV
  • 4.52. GEM srl
  • 4.53. Genzyme Biosurgery Inc.
  • 4.54. GluStitch, Inc.
  • 4.55. Graceduty Company Limited
  • 4.56. Hartmann Group/Hartmann USA
  • 4.57. HemCon Medical Technologies, Inc.
  • 4.58. Hemostasis, LLC
  • 4.59. HyperBranch Medical Technology, Inc.
  • 4.60. Hy-Tape International
  • 4.61. Incisive Surgical, Inc.
  • 4.62. Innovasa Corporation
  • 4.63. Integra Lifesciences Corporation
  • 4.64. Interventional Therapies, LLC
  • 4.65. Johnson & Johnson (Ethicon, Inc., Ethicon Endo-Surgery, Inc., Ethicon Biosurgery)
  • 4.66. Kaketsuken (Chemo-Sero-Therapeutic Research Institute)
  • 4.67. Kensey Nash Corporation
  • 4.68. Kimberly-Clark Health Care
  • 4.69. Kinetic Concepts, Inc.
  • 4.70. Kookbo Chemicals Co., Ltd. (KB Chem.)
  • 4.71. Kuros Biosurgery AG
  • 4.72. Laboratoires Urgo (Urgo Medical)
  • 4.73. LifeBond Ltd.
  • 4.74. LifeScience PLUS
  • 4.75. Lohmann & Rauscher
  • 4.76. Marine Polymer Technologies, Inc.
  • 4.77. Medafor, Inc.
  • 4.78. Medisse
  • 4.79. MedTrade Products, Ltd.
  • 4.80. Meyer-Haake GmbH Medical Innovations
  • 4.81. Molnlycke Health Care AB
  • 4.82. Morris Innovative
  • 4.83. Motex Healthcare Corp.
  • 4.84. NeatStitch Ltd.
  • 4.85. Neomend
  • 4.86. Nobles Medical Technology
  • 4.87. Nycomed (Takeda)
  • 4.88. Ocular Therapeutix, Inc.
  • 4.89. Omrix Biopharmaceuticals Inc. (Johnson & Johnson)
  • 4.90. Opocrin S.p.A
  • 4.91. Orthocon, Inc.
  • 4.92. Orthovita, Inc. (Stryker)
  • 4.93. Pathfinder Cell Therapy, Inc. (formerly SyntheMed)
  • 4.94. Pfizer Inc.
  • 4.95. Plasma Technologies, Inc.
  • 4.96. Pluromed, Inc.
  • 4.97. Polyganics BV
  • 4.98. PolyHeal Ltd.
  • 4.99. ProFibrix BV
  • 4.100. Ranfac Corporation
  • 4.101. Resorba Wundversorgung GmbH & Co. KG
  • 4.102. Salient Surgical Technologies, Inc. (Medtronic)
  • 4.103. Scion Cardio-Vascular, Inc.
  • 4.104. Sea Run Holdings
  • 4.105. Smith & Nephew plc
  • 4.106. St. Jude Medical
  • 4.107. Starch Medical, Inc.
  • 4.108. STB Lifesaving Technologies, Inc.
  • 4.109. Synovis Life Technologies
  • 4.110. Teleflex Medical
  • 4.111. Tenaxis Medical
  • 4.112. ThermoGenesis Corporation
  • 4.113. Thrombotargets Corp.
  • 4.114. TissueSeal, LLC
  • 4.115. Tissuemed Ltd.
  • 4.116. Vascular Solutions, Inc.
  • 4.117. Vivostat A/S
  • 4.118. Wortham Laboratories, Inc.
  • 4.119. Wound Care Technologies, Inc.
  • 4.120. Z-Medica Corporation
  • 4.121. Zimmer
  • 4.122. ZymoGenetics, Inc. (Bristol-Myers Squibb)

APPENDIX: COMPANY DIRECTORY

Show More
Pricing
Get Notified
Email me when related reports are published